Relmada Therapeutics, Inc. RLMD Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s investment purchases?
- Relmada Therapeutics, Inc. (RLMD) reported investment purchases of $149.52M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s investment purchases changed year-over-year?
- Relmada Therapeutics, Inc.'s investment purchases increased by 30544.1% year-over-year, from $487.92K to $149.52M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Relmada Therapeutics, Inc.'s investment purchases has grown at a -21.7% compound annual growth rate (CAGR), from $222.98M to $83.83M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.